Gregory A. Dekaban

The NR1-4 C-terminus interferes with N-methyl-d-aspartate receptor-mediated excitotoxicity: Evidence against a typical T/SXV-PDZ interaction

P. Mattar, K. D. Holmes, G. Dekaban, 2005, Neuroscience.

Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetes.

M. Cameron, C. Strathdee, G. Arreaza, 2000, Human gene therapy.

SARS-COV-2 NSP5 Antagonizes MHC II Expresion by Subverting Histone Deacetylase 2

B. Heit, G. Dekaban, N. Taefehshokr, 2023, bioRxiv.

Cytomegalovirus in the brain: in vitro infection of human brain-derived cells.

G. Rice, G. Dekaban, P. Costello, 1990, The Journal of infectious diseases.

The extent of human cytomegalovirus replication in primary neurons is dependent on host cell differentiation.

G. Rice, G. Dekaban, L. Bambrick, 1994, The Journal of infectious diseases.

An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: a clinical, molecular, and phylogenetic characterisation.

J. Oger, J. Oger, M. Coulthart, 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Engineering of noninfectious HIV-1-like particles containing mutant gp41 glycoproteins as vaccine candidates that allow vaccinees to be distinguished from HIV-1 infectees.

M. Klein, T. Matthews, G. Dekaban, 1999, Virology.

Quantification and characterization of granulocyte macrophage colony-stimulating factor activated human peripheral blood mononuclear cells by fluorine-19 cellular MRI in an immunocompromised mouse model.

J. Dikeakos, P. Foster, G. Dekaban, 2020, Diagnostic and interventional imaging.